Having demonstrated that inhibition of STAT3 not only directly inhibits tumor growth and invasion but also reduces astrocytes' ability to promote tumor growth, this treatment strategy is highly attractive for targeting both tumor cells and their microenvironment. The gene discussed is STAT3; the disease is neoplasm.